These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 21242645)
1. What can the volume of distribution of a macromolecular drugs indicate? Huang JD Drug Metab Pharmacokinet; 2010; 25(6):519-20. PubMed ID: 21242645 [No Abstract] [Full Text] [Related]
2. Drug interaction studies of therapeutic proteins or monoclonal antibodies. Mahmood I; Green MD J Clin Pharmacol; 2007 Dec; 47(12):1540-54. PubMed ID: 17962422 [TBL] [Abstract][Full Text] [Related]
3. Key elements of bioanalytical method validation for macromolecules. Kelley M; DeSilva B AAPS J; 2007 May; 9(2):E156-63. PubMed ID: 17614356 [TBL] [Abstract][Full Text] [Related]
4. Differences in drug metabolism polymorphism between Orientals and Caucasians. Lou YC Drug Metab Rev; 1990; 22(5):451-75. PubMed ID: 2078992 [No Abstract] [Full Text] [Related]
5. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Faed EM Drug Metab Rev; 1984; 15(5-6):1213-49. PubMed ID: 6396057 [No Abstract] [Full Text] [Related]
6. Interview: Interview with Professor Malcolm Rowland. Rowland M Bioanalysis; 2010 Mar; 2(3):385-91. PubMed ID: 21083248 [TBL] [Abstract][Full Text] [Related]
7. Nonlinear pharmacokinetics and their impact on toxicology: illustrated with dioxane. Dietz FK; Stott WT; Ramsey JC Drug Metab Rev; 1982; 13(6):963-81. PubMed ID: 6754319 [No Abstract] [Full Text] [Related]
8. Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms. Kim K; Johnson JA; Derendorf H J Clin Pharmacol; 2004 Oct; 44(10):1083-105. PubMed ID: 15342610 [TBL] [Abstract][Full Text] [Related]
9. Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs. Huh Y; Smith DE; Feng MR Xenobiotica; 2011 Nov; 41(11):972-87. PubMed ID: 21892879 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of infliximab in patients with ankylosing spondylitis. Xu Z; Seitz K; Fasanmade A; Ford J; Williamson P; Xu W; Davis HM; Zhou H J Clin Pharmacol; 2008 Jun; 48(6):681-95. PubMed ID: 18401017 [TBL] [Abstract][Full Text] [Related]
12. Should clinical pharmacokinetic bridging studies between Caucasian and Asian populations be required for approval of monoclonal antibodies? Zhou H; Tsukamoto Y; Davis HM J Clin Pharmacol; 2012 Aug; 52(8):1273-6. PubMed ID: 22135052 [No Abstract] [Full Text] [Related]
13. Pharmacological interactions of monoclonal antibodies. Serra López-Matencio JM; Morell Baladrón A; Castañeda S Med Clin (Barc); 2018 Aug; 151(4):148-155. PubMed ID: 29269128 [TBL] [Abstract][Full Text] [Related]
14. The Upjohn Award Lecture 1981/La Conférence Upjohn 1981. The metabolism of xenobiotics in different populations. Kalow W Can J Physiol Pharmacol; 1982 Jan; 60(1):1-12. PubMed ID: 7039786 [No Abstract] [Full Text] [Related]
15. Receptor-mediated endocytosis of macromolecular conjugates in selective drug delivery. Basu SK Biochem Pharmacol; 1990 Nov; 40(9):1941-6. PubMed ID: 2242027 [No Abstract] [Full Text] [Related]
16. Rigorous mathematical modeling techniques for optimal delivery of macromolecules to the brain. Linninger AA; Somayaji MR; Zhang L; Smitha Hariharan M; Penn RD IEEE Trans Biomed Eng; 2008 Sep; 55(9):2303-13. PubMed ID: 18713700 [TBL] [Abstract][Full Text] [Related]
17. [Significance of lipophilia of drugs for their distribution in the body]. Krieglstein J Dtsch Med Wochenschr; 1973 Aug; 98(32):1509-10. PubMed ID: 4579809 [No Abstract] [Full Text] [Related]
18. Can LC-MS/MS and ligand-binding assays live in harmony for large-molecule bioanalysis? Papadimitriou A; Bansal S; Heinrich J; Staack RF Bioanalysis; 2014; 6(13):1735-7. PubMed ID: 25157480 [No Abstract] [Full Text] [Related]
19. Basic principles of pharmacokinetics. Benet LZ; Zia-Amirhosseini P Toxicol Pathol; 1995; 23(2):115-23. PubMed ID: 7569664 [TBL] [Abstract][Full Text] [Related]
20. Apparent discrimination in the provision of biologic therapy to patients with Crohn's disease according to ethnicity. Farrukh A; Mayberry JF Public Health; 2015 May; 129(5):460-4. PubMed ID: 25779216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]